India’s bioeconomy hits $165.7 Billion as govt unveils fresh biopharma push
Merck launches high-stakes trial of dual-action eye drug aiming to halt leading cause of blindness
Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer
Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra
Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData
Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment
ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Middle East disruption hits thousands of global clinical trials, Phesi warns
Biogen to buy Apellis Pharmaceuticals for $5.6B in rare disease and immunology push
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1775203599)
